Navigation Links
Microscopic passengers to hitch ride on space shuttle

When space shuttle Atlantis rockets into space later this week, it will take along three kinds of microbes so scientists can study how their genetic responses and their ability to cause disease change.

The 'Microbe' experiment, part of the STS-115 space shuttle mission scheduled for launch Aug. 27, will study three common microorganisms -- Salmonella typhimurium, Pseudomonas aeruginosa and Candida albicans -- that have been identified as potential threats to crew health. Sending these microbes into space will allow scientists to investigate the microbes' genetic adaptation and ability to cause infectious disease in microgravity, and to better understand the astronauts' space environment. The results of this experiment will help NASA scientists evaluate the risks to astronauts on future exploration missions planned to go to the moon and Mars.

"Spaceflight holds tremendous potential for the development of novel therapeutics, vaccines and diagnostics to treat, prevent and control infectious diseases," said Cheryl A. Nickerson, Ph.D., the experiment's principal investigator and a researcher at the Biodesign Institute at Arizona State University, Tempe. "Our Microbe experiment will be the first to investigate the effects of spaceflight on the disease-causing potential and gene expression profiles of disease-causing microbes." NASA Ames Research Center, Moffett Field, Calif., developed the Microbe payload for flight.

According to scientists, understanding human biological changes and microbial responses while living in enclosed quarters in space is important to the health, safety and performance of crewmembers and requires further study. The flight microorganisms, which may be carried to spacecraft on the human body and in water or food, have been identified as potential threats to astronaut health based on previous spaceflight missions. Microorganisms also are major causes of human illness on Earth, according to Nickerson.

Prior stud ies have indicated that spaceflight weakens the human immune system and that some microbes become more virulent when grown under conditions that simulate spaceflight, thus increasing the risk of astronauts becoming sick during flight. Whatever the mission or its duration, microbes are present where there are human beings.

This experiment will focus on investigating the effects of spaceflight on three microorganisms commonly found where human beings live. The results will be used in the risk assessment of crew environmental conditions, including drinking water and breathable atmosphere, to help prevent contamination and contagious infection while in space. Scientists also believe this research some day may benefit people on Earth by leading to new therapies to treat infection.

"This experiment requires only the minimum of space shuttle resources, but it has the potential to greatly advance infectious disease research in space and on the ground," said Steven Hing, the experiment's project manager at NASA Ames, in California's Silicon Valley.

With these 'bugs' already present or with the potential to be present in human-occupied spacecraft, this research is applicable to both current and future long-duration flights, Hing noted. Because the microbes will be contained in Group Activation Pack (GAP) hardware that provides three levels of containment, they will pose no threat of exposure to the astronauts. A total of 12 GAPs will fly on the upcoming mission.

"Spaceflight has been shown to induce key changes in both human and microbial cells that are directly relevant to infectious disease, including changes in immune system function, microbial growth rates, antibiotic resistance, and cell surface properties," explained Nickerson. "It is exciting to think of the potential benefit that research in space holds for translation to the clinical bedside by providing a better understanding of how pathogens cause disease that will lead to new ways to treat, prevent and diagnose infectious disease."
'"/>

Source:Arizona State University


Related biology news :

1. Microscopic brain imaging in the palm of your hand
2. Microscopic scaffolding offers a simple solution to treating skin injuries
3. A virus-like hitchhiker may trigger bacterial meningitis
4. Microbes hitchhike across Atlantic on desert dust
5. Viral hitchhiker inhibits Wolbachia bacterias ability to proliferate
6. Evolution of life on Earth may hold key to finding life in outer space
7. Saharas edge studied from ground, air and space to improve water management
8. Plants used to detect gas leaks, from outer space!
9. Scientist-astronaut sends T-cells into space
10. Sandia work launched on space shuttle shows live cells influence growth of nanostructures
11. Harmful Algal Blooms monitored from space in Chile

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
(Date:4/18/2017)... Calif. , April 18, 2017  Socionext Inc., a global ... of a media edge server, the M820, which features the company,s ... recognition software provided by Tera Probe, Inc., will be showcased during ... at the NAB show at the Las Vegas ... ...
(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... ... 10, 2017 , ... USDM Life Sciences , the ... sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer Jaye ... GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to achieving ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
Breaking Biology Technology: